Sectors
BOLT
Bolt Biotherapeutics, Inc.
3.98
2 x 2.83
2 x 5.12
bid
ask
+
0.09
2.31%
2 @ 04:04 PM
4.09 +0.11 (2.76%)
| Ytd | -27.24% | |
| 1y | -22.42% |
3.80
day range
4.04
3.13
52 week range
7.20
| Open | 3.92 | Prev Close | 3.89 | Low | 3.80 | High | 4.04 | Mkt Cap | 7.67M |
| Vol | 4.96K | Avg Vol | 24.46K | EPS | -16.51 | P/E | N/A | Forward P/E | -0.40 |
| Beta | 0.92 | Short Ratio | 0.54 | Inst. Own | 58.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 3.90 | 200-d Avg | 4.76 | 1yr Est | 1.75 |
| Income Statement | |||
| Total Revenue | 5.00K | ||
| Revenues (USD) | 5.00K | ||
| Gross Profit | 5.00K | ||
| Operating Expenses | 8.38M | ||
| Research and Development Expense | 5.15M | ||
| Selling, General and Administrative Expense | 2.42M | ||
| Operating Income | -8.37M | ||
| Net Income | -7.72M | ||
| Net Income Common Stock | -7.72M | ||
| Net Income Common Stock (USD) | -7.72M | ||
| Consolidated Income | -7.72M | ||
| Earnings per Basic Share | -4.57 | ||
| Earnings per Basic Share (USD) | -4.57 | ||
| Earnings per Diluted Share | -4.57 | ||
| Earning Before Interest & Taxes (EBIT) | -7.72M | ||
| Earning Before Interest & Taxes (USD) | -7.72M | ||
| Weighted Average Shares | 1.69M | ||
| Weighted Average Shares Diluted | 1.69M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.06M | ||
| Cash and Equivalents (USD) | 13.06M | ||
| Investments | 6.79M | ||
| Investments Current | 4.74M | ||
| Investments Non-Current | 2.05M | ||
| Current Assets | 20.56M | ||
| Property, Plant & Equipment Net | 17.65M | ||
| Total Assets | 40.34M | ||
| Debt Current | 3.09M | ||
| Total Debt | 21.62M | ||
| Current Liabilities | 7.87M | ||
| Debt Non-Current | 18.53M | ||
| Total Liabilities | 27.70M | ||
| Accumulated Retained Earnings (Deficit) | -475.74M | ||
| Accumulated Other Comprehensive Income | -44.00K | ||
| Shareholders Equity | 12.64M | ||
| Shareholders Equity (USD) | 12.64M | ||
| Assets Non-Current | 19.78M | ||
| Total Debt (USD) | 21.62M | ||
| Deferred Revenue | 1.99M | ||
| Liabilities Non-Current | 19.84M | ||
| Trade and Non-Trade Payables | 868.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 852.00K | ||
| Net Cash Flow from Financing | 19.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.25M | ||
| Capital Expenditure | 673.00K | ||
| Issuance (Purchase) of Equity Shares | 19.00K | ||
| Net Cash Flow from Investing | 7.77M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 7.10M | ||
| Net Cash Flow from Operations | -6.54M | ||
| Share Based Compensation | 552.00K | ||